New York State Common Retirement Fund Has $31.33 Million Stake in Axon Enterprise, Inc $AXON

New York State Common Retirement Fund lifted its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 4.4% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 37,839 shares of the biotechnology company’s stock after purchasing an additional 1,600 shares during the quarter. New York State Common Retirement Fund’s holdings in Axon Enterprise were worth $31,328,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Brighton Jones LLC purchased a new stake in Axon Enterprise in the 4th quarter worth approximately $480,000. Arkadios Wealth Advisors grew its holdings in shares of Axon Enterprise by 104.1% during the 1st quarter. Arkadios Wealth Advisors now owns 1,651 shares of the biotechnology company’s stock valued at $868,000 after acquiring an additional 842 shares in the last quarter. Jefferies Financial Group Inc. increased its stake in shares of Axon Enterprise by 88.7% in the first quarter. Jefferies Financial Group Inc. now owns 4,868 shares of the biotechnology company’s stock worth $2,560,000 after acquiring an additional 2,288 shares during the last quarter. Cheviot Value Management LLC purchased a new stake in shares of Axon Enterprise during the first quarter worth $86,000. Finally, IPG Investment Advisors LLC raised its holdings in shares of Axon Enterprise by 28.1% during the first quarter. IPG Investment Advisors LLC now owns 2,230 shares of the biotechnology company’s stock worth $1,173,000 after acquiring an additional 489 shares in the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, Director Jeri Williams sold 100 shares of the firm’s stock in a transaction on Thursday, September 11th. The shares were sold at an average price of $752.54, for a total value of $75,254.00. Following the transaction, the director directly owned 1,416 shares in the company, valued at approximately $1,065,596.64. This trade represents a 6.60% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction on Friday, November 7th. The stock was sold at an average price of $591.04, for a total transaction of $5,910,400.00. Following the completion of the transaction, the chief executive officer owned 3,023,982 shares in the company, valued at $1,787,294,321.28. This trade represents a 0.33% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 38,622 shares of company stock valued at $26,439,364 in the last quarter. 4.40% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several brokerages have weighed in on AXON. Royal Bank Of Canada started coverage on Axon Enterprise in a research report on Monday, November 17th. They issued an “outperform” rating and a $860.00 target price on the stock. Northland Securities set a $800.00 price target on Axon Enterprise in a research note on Tuesday, August 5th. UBS Group dropped their price objective on Axon Enterprise from $840.00 to $610.00 and set a “neutral” rating on the stock in a report on Wednesday, November 5th. Raymond James Financial reiterated an “outperform” rating and issued a $855.00 target price (up from $645.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Finally, Craig Hallum raised shares of Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 target price for the company in a research report on Tuesday, August 5th. Fifteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $814.00.

Axon Enterprise Stock Up 1.3%

Shares of AXON stock opened at $540.14 on Monday. The stock’s 50 day simple moving average is $658.44 and its 200 day simple moving average is $726.83. Axon Enterprise, Inc has a twelve month low of $469.24 and a twelve month high of $885.91. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. The company has a market capitalization of $42.62 billion, a price-to-earnings ratio of 133.37, a PEG ratio of 29.49 and a beta of 1.45.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Wednesday, November 5th. The biotechnology company reported $1.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.46). Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The company had revenue of $710.64 million for the quarter, compared to the consensus estimate of $704.83 million. During the same period in the previous year, the company earned $1.45 EPS. The firm’s revenue for the quarter was up 30.6% compared to the same quarter last year. As a group, research analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.